CN105412723A - Traditional Chinese medicine patch for treating osteoproliferation and nursing method - Google Patents
Traditional Chinese medicine patch for treating osteoproliferation and nursing method Download PDFInfo
- Publication number
- CN105412723A CN105412723A CN201510669915.6A CN201510669915A CN105412723A CN 105412723 A CN105412723 A CN 105412723A CN 201510669915 A CN201510669915 A CN 201510669915A CN 105412723 A CN105412723 A CN 105412723A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- grams
- osteoproliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine patch for treating osteoproliferation. According to traditional Chinese medicine, oldness, weakness, liver and kidney depletion, qi stagnation and blood stasis are inner causes of osteoproliferation, wind-cold-wetness evil invasion and trauma strain are the main outer causes of osteoproliferation, and therefore sclerotin generates loading type inflammatory inflammatory changes, qi and blood loss, blood stasis and stagnation and unsmooth main and collateral channels are caused, and osteoproliferation is caused. The patch is prepared from traditional Chinese medicine including crataeva leaves, Indian kalimeris herb, Laurocerasus zippeliana (Miq.) Yu et Lu, Kalopanax septemlobus (Thunb.) Koidz. roots, Osmanthus delavayi Franch., radix semiaquilegiae, Franchet Groundcherry, Drosera burmanni Vahl, Smilax stans Maxim., Gnetum montanum Markgr., Salix hypoleuca and Aralia echinocaulis Hand.- Mazz.. It is proved through clinical tests that the total effective rate is 98.0% and is obviously superior to the total effective rate of 70.0% of the contrast group.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of homogeneous design method for the treatment of bone matrix hyperplasia.
Background technology
Hyperosteogeny is for a kind of osteoarthrosis disease caused by osteoarthrosis generation hypertrophy and pathological change, mostly occurs at large, movable many positions of bearing a heavy burden, the most often involves vertebra, especially lumbar vertebra and cervical vertebra common.Be often engender symptom, initial conscious ankylosis, pain, especially after having a rest, react comparatively obvious, after movable, stiffness disappears for its feature.Along with joint margins bone lip or bony spur are formed, not only pain increases the weight of, and rubs during joint motion, affects joint motion amplitude, and bony spur stimulates the blood vessel, nerve etc. of local, causes aseptic inflammation, the shakiness of secondary spinal column allomeric function.The traditional Chinese medical science, in the past to the cause of disease of hyperosteogeny, based on " kidney governing bones " thought, thinks that deficiency of kidney-QI is its basic endogenous cause of ill, and to strain, the accumulation of wound is external motivation.Therefore treating bone matrix hyperplasia, is principle mainly with the strong muscle of the kidney invigorating.But along with the raising of diagnostic level in recent years, the recall rate of hyperosteogeny increases greatly, and find increasing adolescent patients, they there is no syndrome of suffering from a deficiency of the kidney, but morbidity and daily impairment caused by overstrain have very big relation.This kind of hyperosteogeny patient etiology and pathogenesis is different from middle-aged and elderly people deficiency syndrome, and disease arises from wound, strain, and joint frays, feel wind-cold damp pathogen again, make through BI-syndrome involved the blood vessels resistance, stagnation of QI-blood, blood network coagulate puckery must not declare logical, medullization is raw unfavorable, and accumulating in the course of time, it is turbid to turn to expectorant, and pent-up is superfluous, the excess syndrome for hyperosteogeny that can return.Therefore should based on tonneau in treatment.Only have by blood circulation promoting and blood stasis dispelling, dispelling cold by warming the meridian, just can general rule not bitterly, to receive good effect.Current doctor trained in Western medicine adopts non-hormone antiinflammation pain-stopping pharmaceutical and operative treatment, and effect is very limited, there is no special effective therapy so far.Applicant in clinical practice, adopts treatment by Chinese herbs bone matrix hyperplasia, achieves good curative effect, without obvious toxic-side effects, evident in efficacy, especially adopts Chinese medicine application no pain, convenient enforcement, and patient is easy to accept.
Summary of the invention
The object of this invention is to provide a kind of homogeneous design method for the treatment of bone matrix hyperplasia.Bone matrix hyperplasia belongs to " arthromyodynia ", " rheumatism involving the bone " category according to clinical manifestation and age of onset.Discuss from the traditional Chinese medical science, the endogenous cause of ill of primary disease is often worn with age, caused by liver and kidney deficiency, qi depression to blood stasis, exopathogenic factor is then mainly the intrusion of wind-cold damp pathogen, and wound strain, causes sclerotin to produce loading inflammatory pathological change, QI and blood is damaged partially, blood stasis stagnates, meridians are got along well and fall ill, be characterized in that local blockage of meridian is main.
The object of the invention is to be achieved through the following technical solutions, the homogeneous design method of this treatment bone matrix hyperplasia is made up of the Chinese medicine of following weight portion: Folium cratevae unilocularis 7-15 part, Herba Kalimeridis 7-15 part, Ramulus Et Folium Adhatodae Vasicae 5-10 part, Radix Kalopanacis 5-10 part, Radix Polygalae Wattersii 6-12 part, Radix Semiaquilegiae 6-12 part, Physalis alkekengi L. var. francheti (Mast.) Makino 6-12 part, Herba droserae burmannii 8-15 part, Rhizoma et radix smilacis santis 9-15 part, Caulis Gneti 9-15 part, Radix Salicis Hypoleucae 3-7 part, Cortex Araliae Echinocaulis Radicis 3-7 part.
Preferred: Folium cratevae unilocularis 11 parts, Herba Kalimeridis 11 parts, Ramulus Et Folium Adhatodae Vasicae 8 parts, Radix Kalopanacis 8 parts, Radix Polygalae Wattersii 9 parts, Radix Semiaquilegiae 9 parts, Physalis alkekengi L. var. francheti (Mast.) Makino 9 parts, Herba droserae burmannii 13 parts, Rhizoma et radix smilacis santis 13 parts, Caulis Gneti 13 parts, Radix Salicis Hypoleucae 5 parts of, Cortex Araliae Echinocaulis Radicis 5 parts.
Preparation method: grind to the powder above-mentioned raw material of Chinese medicine mixing, then with vaseline furnishing pasty state.
Fang Zhong: Folium cratevae unilocularis heat clearing away, stomach invigorating, removing toxic substances; Herba Kalimeridis heat clearing and blood cooling, expelling wind and cold, removing toxic substances; Ramulus Et Folium Adhatodae Vasicae promoting blood circulation to remove blood stasis; Radix Kalopanacis cool the blood dissipate blood stasis, expelling wind and removing dampness; Radix Polygalae Wattersii strengthening by means of tonics, medicine powder for relaxing muscle blood, promoting blood circulation and detoxication; Radix Semiaquilegiae heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, diuresis; Physalis alkekengi L. var. francheti (Mast.) Makino heat-clearing and toxic substances removing; The long-pending poison of Herba droserae burmannii solution, antiinflammatory removing the necrotic tissue; Rhizoma et radix smilacis santis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, activating blood cirulation to regulate QI flow; Caulis Gneti expelling wind and removing dampness, promoting blood circulation to remove blood stasis; Radix Salicis Hypoleucae expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling; Cortex Araliae Echinocaulis Radicis expelling wind and removing dampness, promoting flow of QI and blood, subduing swelling and detoxicating.
Clinical data
1, the routine patient of physical data 100 all carrys out self-Out-patient Department, is divided into treatment group and each 50 examples of matched group.Treatment group cervical spondylosis 10 example, lumbar vertebra hyperosteogeny 15 example, knee joint hyperosteogeny 15 example, macLean-Maxwell disease 10 example; Man 28 example, female 22 example; 39 years old mean age, the course of disease is the shortest 60 days, the longest 5 years.Matched group cervical spondylosis 15 example, lumbar vertebra hyperosteogeny 10 example, knee joint hyperosteogeny 15 example, macLean-Maxwell disease 10 example; Man 30 example, female 20 example; 41 years old mean age, the course of disease is the shortest 65 days, the longest 4 years, and all cases is all taken the photograph sheet inspection through x-ray and made a definite diagnosis.
2, diagnostic criteria pathological changes joint part pain is uncomfortable, face upward bow, stretch in the wrong, change one's position malfunctioning, can alleviate after most activity, hyperactivity or position change can make pain increase the weight of, especially rise morning or sitting is stood up time pain the most acute, there is obvious tenderness at hypertrophy position.During the morbidity of neck, lumbar vertebra, except above-mentioned symptom, multidirectional upper and lower limb is radiated pain, and with upper and lower acroanesthesia in various degree.X-ray is taken the photograph sheet and is seen that pathological changes joint vertebral rim has lip sample projection, stenosis of disc space and asymmetric, and during knee hyperplasia, in visible tibia, between lateral condyle and joint circumferential edges bone has hyperosteogeny.
3, Therapeutic Method treatment group uses homogeneous design method of the present invention, take Folium cratevae unilocularis 11 grams, Herba Kalimeridis 11 grams, Ramulus Et Folium Adhatodae Vasicae 8 grams, Radix Kalopanacis 8 grams, Radix Polygalae Wattersii 9 grams, Radix Semiaquilegiae 9 grams, Physalis alkekengi L. var. francheti (Mast.) Makino 9 grams, Herba droserae burmannii 13 grams, Rhizoma et radix smilacis santis 13 grams, Caulis Gneti 13 grams, Radix Salicis Hypoleucae 5 grams of, Cortex Araliae Echinocaulis Radicis 5 grams, grind to the powder above-mentioned raw material of Chinese medicine mixing, again with vaseline furnishing pasty state, each medication about 15 grams is applied on gauze, be affixed on bone matrix hyperplasia position and pain spot, multiple position can be pasted 1 time, within every 3 days, change dressings 1 time.General to be January 1 course for the treatment of, treat 3 courses for the treatment of; Matched group western medicine treatment routinely.
4, criterion of therapeutical effect recovery from illness: clinical symptom disappearance, local movement freely, is recovered normally to work, and x line check hyperosteogeny does not have growth, follows up a case by regular visits to without recurrence after 1 year.Effective: clinical symptoms disappears substantially, local movement, without obviously limited, can recover original work.Effective: clinical symptoms is obviously improved, tired or can symptom be occurred after catching cold, but comparatively before alleviate to some extent, lighter work can be participated in.Invalid: 3 courses for the treatment of are treated in medication, clinical symptoms is improved not obvious, and joint movement disorder is unchanged, very then increases the weight of.
5, therapeutic outcome
Two therapeutic outcomes of carefully treating after 3 courses for the treatment of are as shown in the table
| Group | n | Recovery from illness | Effective | Effectively | Invalid | Total effective rate |
| Treatment group | 50 | 30 | 15 | 4 | 1 | 98％ |
| Matched group | 50 | 20 | 10 | 5 | 15 | 70％ |
Two groups are compared, and treatment group cure rate, total effective rate are obviously better than matched group, and difference has significance, (P < 0.01).
Detailed description of the invention
Embodiment one: take Folium cratevae unilocularis 11 grams, Herba Kalimeridis 11 grams, Ramulus Et Folium Adhatodae Vasicae 8 grams, Radix Kalopanacis 8 grams, Radix Polygalae Wattersii 9 grams, Radix Semiaquilegiae 9 grams, Physalis alkekengi L. var. francheti (Mast.) Makino 9 grams, Herba droserae burmannii 13 grams, Rhizoma et radix smilacis santis 13 grams, Caulis Gneti 13 grams, Radix Salicis Hypoleucae 5 grams of, Cortex Araliae Echinocaulis Radicis 5 grams, grind to the powder above-mentioned raw material of Chinese medicine mixing, more for subsequent use with vaseline furnishing pasty state.
Embodiment two: take Folium cratevae unilocularis 15 grams, Herba Kalimeridis 7 grams, Ramulus Et Folium Adhatodae Vasicae 10 grams, Radix Kalopanacis 5 grams, Radix Polygalae Wattersii 6 grams, Radix Semiaquilegiae 12 grams, Physalis alkekengi L. var. francheti (Mast.) Makino 6 grams, Herba droserae burmannii 15 grams, Rhizoma et radix smilacis santis 9 grams, Caulis Gneti 15 grams, Radix Salicis Hypoleucae 3 grams of, Cortex Araliae Echinocaulis Radicis 7 grams, grind to the powder above-mentioned raw material of Chinese medicine mixing, more for subsequent use with vaseline furnishing pasty state.
Embodiment three: take Folium cratevae unilocularis 7 grams, Herba Kalimeridis 15 grams, Ramulus Et Folium Adhatodae Vasicae 5 grams, Radix Kalopanacis 10 grams, Radix Polygalae Wattersii 12 grams, Radix Semiaquilegiae 6 grams, Physalis alkekengi L. var. francheti (Mast.) Makino 12 grams, Herba droserae burmannii 8 grams, Rhizoma et radix smilacis santis 15 grams, Caulis Gneti 9 grams, Radix Salicis Hypoleucae 7 grams of, Cortex Araliae Echinocaulis Radicis 3 grams, grind to the powder above-mentioned raw material of Chinese medicine mixing, more for subsequent use with vaseline furnishing pasty state.
Claims (2)
1. treat a herbal application agent for bone matrix hyperplasia, it is characterized in that this homogeneous design method is made up of the Chinese medicine of following weight portion: Folium cratevae unilocularis 7-15 part, Herba Kalimeridis 7-15 part, Ramulus Et Folium Adhatodae Vasicae 5-10 part, Radix Kalopanacis 5-10 part, Radix Polygalae Wattersii 6-12 part, Radix Semiaquilegiae 6-12 part, Physalis alkekengi L. var. francheti (Mast.) Makino 6-12 part, Herba droserae burmannii 8-15 part, Rhizoma et radix smilacis santis 9-15 part, Caulis Gneti 9-15 part, Radix Salicis Hypoleucae 3-7 part, Cortex Araliae Echinocaulis Radicis 3-7 part.
2. a kind of herbal application agent for the treatment of bone matrix hyperplasia as claimed in claim 1, is characterized in that this homogeneous design method is made up of the Chinese medicine of following weight portion: preferred: Folium cratevae unilocularis 11 parts, Herba Kalimeridis 11 parts, Ramulus Et Folium Adhatodae Vasicae 8 parts, Radix Kalopanacis 8 parts, Radix Polygalae Wattersii 9 parts, Radix Semiaquilegiae 9 parts, Physalis alkekengi L. var. francheti (Mast.) Makino 9 parts, Herba droserae burmannii 13 parts, Rhizoma et radix smilacis santis 13 parts, Caulis Gneti 13 parts, Radix Salicis Hypoleucae 5 parts of, Cortex Araliae Echinocaulis Radicis 5 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510669915.6A CN105412723A (en) | 2015-10-09 | 2015-10-09 | Traditional Chinese medicine patch for treating osteoproliferation and nursing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510669915.6A CN105412723A (en) | 2015-10-09 | 2015-10-09 | Traditional Chinese medicine patch for treating osteoproliferation and nursing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105412723A true CN105412723A (en) | 2016-03-23 |
Family
ID=55491564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510669915.6A Pending CN105412723A (en) | 2015-10-09 | 2015-10-09 | Traditional Chinese medicine patch for treating osteoproliferation and nursing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105412723A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393776A (en) * | 2013-08-01 | 2013-11-20 | 金琮人 | Traditional Chinese medicine for treating orthopedic diseases |
-
2015
- 2015-10-09 CN CN201510669915.6A patent/CN105412723A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393776A (en) * | 2013-08-01 | 2013-11-20 | 金琮人 | Traditional Chinese medicine for treating orthopedic diseases |
Non-Patent Citations (1)
| Title |
|---|
| 王金荣等0: "《实用中医老年治疗手册》", 30 November 1995, 上海科学技术文献出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN101108226A (en) | Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN102920876A (en) | External Chinese medicinal composition for treating knee osteoarthritis | |
| CN106039245A (en) | External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof | |
| CN104367921A (en) | Traditional Chinese medicine composition for treating pains in necks, shoulders, waists and legs | |
| CN107320698A (en) | A kind of Chinese medicine compound prescription for treating person in middle and old age's nerve root cervical vertebra sickness and its application | |
| CN102125612B (en) | Chinese medicinal preparation for treating acute lumbar sprain | |
| CN102697999A (en) | Externally applied Chinese medicine for treating rheumatism | |
| CN105412723A (en) | Traditional Chinese medicine patch for treating osteoproliferation and nursing method | |
| CN102133380B (en) | Medicament for treating cervical spondylosis | |
| CN102283952B (en) | Bone strengthening and marrow increasing Chinese prepared medicine for treating bone diseases | |
| CN101757329B (en) | Traditional Chinese medicine thrombolysis capsule for treating cerebral thrombosis | |
| CN104547222A (en) | Traditional Chinese medicine patching agent for treating hyperostosis | |
| CN101708266B (en) | Oral herbal decoction for treating osteoporosis | |
| CN103977128A (en) | Traditional Chinese medicine composition for treating postoperative lumbar spinal stenosis | |
| CN105326926B (en) | A kind of external medicine preparation that treating muscles along the regular meridians disease, preparation method and application | |
| CN115025187B (en) | Traditional Chinese medicine composition for treating lumbago, acupoint plaster and preparation method and application thereof | |
| CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
| CN106729521A (en) | It is a kind of to treat Chinese medicine preparation of apoplexy and preparation method thereof | |
| CN106266788A (en) | A kind of treat the soothing the liver removing toxic substances of gouty arthritis, QiReLiShi herbs compositions | |
| CN104547915A (en) | Traditional Chinese medicine composition for treating traumatic injury and medicinal liquor | |
| CN105125978A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof | |
| CN104435229A (en) | Traditional Chinese medicine agent for treating cervical spondylosis and preparation method thereof | |
| CN113262290A (en) | Plaster for treating pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160323 |